Compare Quest Diagnostics Inc (DGX) vs Advanced Drainage Systems Inc (WMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Advanced Drainage Systems Inc — how do they compare? Quest Diagnostics Inc trades at $230.97 (market cap $25.48B), while Advanced Drainage Systems Inc trades at $125.79 (market cap $9.52B). The key difference: Quest Diagnostics Inc is far larger — about 2.7× Advanced Drainage Systems Inc's market cap, and Quest Diagnostics Inc pays the higher dividend (1.49%). Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Advanced Drainage Systems Inc for 43 Days on average.
| DGX | WMS | |
|---|---|---|
Market Cap | $25.48B | $9.52B |
Volume | 941,866 | 907,564 |
Sector | Health | Basic Materials |
52-Week High | $247.45 | $175.38 |
52-Week Low | $173.49 | $125.33 |
Typical Hold Time | 56 Days | 43 Days |
Enterprise Value | $31.23B | $11.12B |
Dividend Yield | 1.49% | 0.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.81, up 1.68% today, with a bullish earnings trend after beating EPS estimates for three consecutive quarters. The stock shows a mixed technical picture with a bearish overall signal but trades near key support at $228. Revenue growth accelerated to $11.04B in 2025, and the company maintains solid profitability with a 9.19% net income margin. Recent news highlights growth in consumer testing and a partnership with Apple Health, though Medicare reimbursement cuts pose a headwind.
The outlook is cautiously optimistic, supported by strong fundamentals and a consensus price target of $250 offering 8% upside. Key opportunities include demand for advanced diagnostics and AI adoption, while risks center on regulatory pressure and rising debt levels. Analyst sentiment is mixed with a slight hold bias, reflecting balanced growth prospects against near-term challenges.
Advanced Drainage Systems (WMS) trades at $126.21, up 0.1% on the day, with a bearish technical signal from moving averages despite neutral oscillators. The company reported strong Q2 2026 earnings of $2.49 per share, beating estimates, and maintains solid profitability with a 14% net income margin. Recent news highlights institutional activity and the release of a sustainability report, while analyst consensus leans bullish with a $188.70 price target.
The outlook for WMS is supported by earnings beats and structural growth in water management solutions, but near-term risks include a projected negative cash flow in 2026 and competitive pressures. The stock offers potential upside relative to analyst targets, though investors should weigh execution risks against the company's market position and margin strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Advanced Drainage Systems Inc
Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe
Read more on WMS →
